BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Aguanno S, Mallone F, Marenco M, Del Bufalo D, Moramarco A. Hypoxia-dependent drivers of melanoma progression. J Exp Clin Cancer Res 2021;40:159. [PMID: 33964953 DOI: 10.1186/s13046-021-01926-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Tai Z, Miao F, Huang H, Zhu Q, Bao L, Chen Z. Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect. Front Oncol 2022;12:1046102. [PMID: 36620597 DOI: 10.3389/fonc.2022.1046102] [Reference Citation Analysis]
2 Rizzetto G, Lucarini G, De Simoni E, Molinelli E, Mattioli-Belmonte M, Offidani A, Simonetti O. Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma. Int J Mol Sci 2022;24. [PMID: 36613587 DOI: 10.3390/ijms24010144] [Reference Citation Analysis]
3 Ene CD, Nicolae I. Hypoxia-Nitric Oxide Axis and the Associated Damage Molecular Pattern in Cutaneous Melanoma. J Pers Med 2022;12. [PMID: 36294785 DOI: 10.3390/jpm12101646] [Reference Citation Analysis]
4 Yin Y, Du W, Li F. The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression. Front Oncol 2022;12:1008770. [DOI: 10.3389/fonc.2022.1008770] [Reference Citation Analysis]
5 Maccio U, Mihic A, Lenggenhager D, Kolm I, Mittmann C, Heikenwälder M, Lorentzen A, Mihic-probst D. Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance. IJMS 2022;23:10745. [DOI: 10.3390/ijms231810745] [Reference Citation Analysis]
6 Zhang X, Qiu J, Huang F, Han P, Shan K, Zhang C. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses. Exp Eye Res 2022;223:109214. [PMID: 35981602 DOI: 10.1016/j.exer.2022.109214] [Reference Citation Analysis]
7 Jiao B, Liu S, Zhao H, Zhuang Y, Ma S, Lin C, Hu J, Liu X. Hypoxia-responsive circRNAs: A novel but important participant in non-coding RNAs ushered toward tumor hypoxia. Cell Death Dis 2022;13:666. [PMID: 35915091 DOI: 10.1038/s41419-022-05114-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Xu H, Liu H, Li Z, Xu Q, Lin N, Li X. BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response. Clin Cosmet Investig Dermatol 2022;15:1109-17. [PMID: 35747741 DOI: 10.2147/CCID.S370969] [Reference Citation Analysis]
9 Kang Z, Wang J, Huang W, Liu J, Yan W. Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis. Front Cell Dev Biol 2022;10:874429. [DOI: 10.3389/fcell.2022.874429] [Reference Citation Analysis]
10 Lucarini G, Molinelli E, Licini C, Rizzetto G, Radi G, Goteri G, Mattioli-Belmonte M, Offidani A, Simonetti O. Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma. Int J Mol Sci 2022;23:4775. [PMID: 35563166 DOI: 10.3390/ijms23094775] [Reference Citation Analysis]
11 Del Bufalo D, Di Martile M, Valentini E, Manni I, Masi I, D'amore A, Filippini A, Nicoletti C, Zaccarini M, Cota C, Castro MV, Quezada MJ, Rosanò L, Lopez-bergami P, D'aguanno S. Bcl-2-like protein-10 increases aggressive features of melanoma cells. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2022.00068] [Reference Citation Analysis]
12 Vidal A, Redmer T. Tracking of Melanoma Cell Plasticity by Transcriptional Reporters. Int J Mol Sci 2022;23:1199. [PMID: 35163127 DOI: 10.3390/ijms23031199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Takabe P, Siiskonen H, Rönkä A, Kainulainen K, Pasonen-seppänen S. The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma. Front Oncol 2022;11:811434. [DOI: 10.3389/fonc.2021.811434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Piotrowska A, Beserra FP, Wierzbicka JM, Nowak JI, Żmijewski MA. Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells. Front Oncol 2021;11:763895. [PMID: 35004285 DOI: 10.3389/fonc.2021.763895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mukherjee N, Dart CR, Amato CM, Honig-frand A, Lambert JR, Lambert KA, Robinson WA, Tobin RP, Mccarter MD, Couts KL, Fujita M, Norris DA, Shellman YG. Expression differences in BCL2 family members between uveal and cutaneous melanomas account for varying sensitivity to BH3 mimetics. Journal of Investigative Dermatology 2021. [DOI: 10.1016/j.jid.2021.11.035] [Reference Citation Analysis]
16 Boussadia Z, Gambardella AR, Mattei F, Parolini I. Acidic and Hypoxic Microenvironment in Melanoma: Impact of Tumour Exosomes on Disease Progression. Cells 2021;10:3311. [PMID: 34943819 DOI: 10.3390/cells10123311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tan NKW, Yap DWT, Tan BKJ, Teo YH, Tan EKH, Chan JY, Lee HY, See A, Toh ST. The association of obstructive sleep apnea with melanoma incidence and mortality: a meta-analysis of 5,276,451 patients. Sleep Med 2021;88:213-20. [PMID: 34794048 DOI: 10.1016/j.sleep.2021.10.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Khalyfa A, Trzepizur W, Gileles-Hillel A, Qiao Z, Sanz-Rubio D, Marin JM, Martinez-Garcia MA, Campos-Rodriguez F, Almendros I, Farre R, Sanchez-de-la-Torre M, García-Río F, Gozal D. Heterogeneity of Melanoma Cell Responses to Sleep Apnea-Derived Plasma Exosomes and to Intermittent Hypoxia. Cancers (Basel) 2021;13:4781. [PMID: 34638272 DOI: 10.3390/cancers13194781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Geng B, Zhu Y, Yuan Y, Bai J, Dou Z, Sui A, Luo W. Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis. Front Oncol 2021;11:714646. [PMID: 34476217 DOI: 10.3389/fonc.2021.714646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 D'Aguanno S. Special Issue "Precision Oncology in Melanoma Progression". Int J Mol Sci 2021;22:7723. [PMID: 34299343 DOI: 10.3390/ijms22147723] [Reference Citation Analysis]